28196360|t|Clinical Relevance of Pleural Effusion in Patients with Pulmonary Embolism
28196360|a|Data regarding pleural effusion due to pulmonary embolism (PE) are limited. The aim of this study was to investigate the clinical characteristics of PE patients with pleural effusion caused by PE. Patients with PE were retrospectively analyzed and divided into 2 groups based on computed tomography: a group with pleural effusion due to PE (effusion group) and a group without pleural effusion (control group). Clinical characteristics were compared between the 2 groups. The study population consisted of the effusion group (n = 127) and the control group (n = 651). Serum C-reactive protein (CRP) level was significantly higher in the effusion group than in the control group. The percentages of high-risk Simplified PE Severity Index (57 vs. 47%, p = 0.008), central PE (84 vs. 73%, p = 0.013), right ventricular dilation (45 vs. 36%, p = 0.053), and pulmonary infarction (40 vs. 8%, p < 0.001) were higher in the effusion group than in the control group. Multivariate analysis demonstrated that pulmonary infarction (odds ratio [OR] 6.20, 95% confidence interval [CI] 3.49-10.91, p < 0.001) and CRP level (OR 1.05, 95% CI 1.101-1.09, p = 0.023) were independent predictors of pleural effusion due to PE. The presence of pleural effusion was not a predictor of short-term outcomes or length of hospital stay. Patients with more severe PE are likely to have pleural effusion caused by PE. However, pleural effusion was not a proven predictor of short-term outcome or length of hospital stay. Pulmonary infarction and CRP levels were independent risk factors for the development of pleural effusion.
28196360	0	8	Clinical	T080	C0205210
28196360	9	18	Relevance	T080	C2347946
28196360	22	38	Pleural Effusion	T047	C0032227
28196360	42	50	Patients	T101	C0030705
28196360	56	74	Pulmonary Embolism	T047	C0034065
28196360	75	79	Data	T078	C1511726
28196360	90	106	pleural effusion	T047	C0032227
28196360	114	132	pulmonary embolism	T047	C0034065
28196360	134	136	PE	T047	C0034065
28196360	142	149	limited	T169	C0439801
28196360	155	158	aim	T078	C1947946
28196360	167	172	study	T062	C0008972
28196360	180	191	investigate	T169	C1292732
28196360	196	220	clinical characteristics	T201	C0683325
28196360	224	226	PE	T047	C0034065
28196360	227	235	patients	T101	C0030705
28196360	241	257	pleural effusion	T047	C0032227
28196360	268	270	PE	T047	C0034065
28196360	272	280	Patients	T101	C0030705
28196360	286	288	PE	T047	C0034065
28196360	294	318	retrospectively analyzed	T062	C0035363
28196360	323	330	divided	T169	C0332849
28196360	338	344	groups	T078	C0441833
28196360	354	373	computed tomography	T060	C0040405
28196360	377	382	group	T078	C0441833
28196360	388	404	pleural effusion	T047	C0032227
28196360	412	414	PE	T047	C0034065
28196360	416	430	effusion group	T078	C0441833
28196360	438	443	group	T078	C0441833
28196360	452	468	pleural effusion	T047	C0032227
28196360	470	483	control group	T096	C0009932
28196360	486	510	Clinical characteristics	T201	C0683325
28196360	516	524	compared	T052	C1707455
28196360	539	545	groups	T078	C0441833
28196360	551	556	study	T062	C0008972
28196360	557	567	population	T098	C1257890
28196360	585	599	effusion group	T078	C0441833
28196360	618	631	control group	T096	C0009932
28196360	643	679	Serum C-reactive protein (CRP) level	T059	C1277266
28196360	684	704	significantly higher	T081	C4055637
28196360	712	726	effusion group	T078	C0441833
28196360	739	752	control group	T096	C0009932
28196360	758	769	percentages	T081	C0439165
28196360	773	782	high-risk	T033	C0332167
28196360	783	811	Simplified PE Severity Index	T081	C0036859
28196360	825	826	p	T081	C1709380
28196360	837	847	central PE	T047	C0034065
28196360	861	862	p	T081	C1709380
28196360	873	899	right ventricular dilation	T019	C0344893
28196360	913	914	p	T081	C1709380
28196360	929	949	pulmonary infarction	T047	C0034074
28196360	962	963	p	T081	C1709380
28196360	978	984	higher	T080	C0205250
28196360	992	1006	effusion group	T078	C0441833
28196360	1019	1032	control group	T096	C0009932
28196360	1034	1055	Multivariate analysis	T081	C0026777
28196360	1074	1094	pulmonary infarction	T047	C0034074
28196360	1096	1106	odds ratio	T081	C0028873
28196360	1108	1110	OR	T081	C0028873
28196360	1122	1141	confidence interval	T081	C0009667
28196360	1143	1145	CI	T081	C0009667
28196360	1159	1160	p	T081	C1709380
28196360	1174	1183	CRP level	T034	C0428528
28196360	1185	1187	OR	T081	C0028873
28196360	1198	1200	CI	T081	C0009667
28196360	1213	1214	p	T081	C1709380
28196360	1229	1240	independent	T078	C0085862
28196360	1241	1251	predictors	T078	C2698872
28196360	1255	1271	pleural effusion	T047	C0032227
28196360	1279	1281	PE	T047	C0034065
28196360	1299	1315	pleural effusion	T047	C0032227
28196360	1326	1335	predictor	T078	C2698872
28196360	1339	1349	short-term	T079	C0443303
28196360	1350	1358	outcomes	T169	C1274040
28196360	1362	1385	length of hospital stay	T079	C0023303
28196360	1387	1395	Patients	T101	C0030705
28196360	1406	1412	severe	T080	C0205082
28196360	1413	1415	PE	T047	C0034065
28196360	1435	1451	pleural effusion	T047	C0032227
28196360	1452	1458	caused	T078	C0085978
28196360	1462	1464	PE	T047	C0034065
28196360	1475	1491	pleural effusion	T047	C0032227
28196360	1502	1508	proven	T080	C0456369
28196360	1509	1518	predictor	T078	C2698872
28196360	1522	1532	short-term	T079	C0443303
28196360	1533	1540	outcome	T169	C1274040
28196360	1544	1567	length of hospital stay	T079	C0023303
28196360	1569	1589	Pulmonary infarction	T047	C0034074
28196360	1594	1604	CRP levels	T034	C0428528
28196360	1610	1621	independent	T078	C0085862
28196360	1622	1634	risk factors	T033	C0035648
28196360	1643	1654	development	T169	C1527148
28196360	1658	1674	pleural effusion	T047	C0032227